Table 5. Adverse Events by Risk Groups .... | American Society of Hematology

Table 5.

Adverse Events by Risk Groups

	Total	Risk Group
	Total	R1	R2	R3
No. of patients	413	71	167	175

Early death	3	0	0	3
Progression	27	0	2	25
Death unrelated to tumor	11	0	3	8
Second malignancy	2	0	1	1

Lost to follow-up^5-150	21	4	12	5

	Total	Risk Group
	Total	R1	R2	R3
No. of patients	413	71	167	175

Early death	3	0	0	3
Progression	27	0	2	25
Death unrelated to tumor	11	0	3	8
Second malignancy	2	0	1	1

Lost to follow-up^5-150	21	4	12	5

After event-free follow-up duration of 0.2 to 5.46 years (median, 1.73 years).